JUVENILE PSORIATIC ARTHRITIS
Clinical trials for JUVENILE PSORIATIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE PSORIATIC ARTHRITIS trials appear
Sign up with your email to follow new studies for JUVENILE PSORIATIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New arthritis drug trial opens for kids as young as 2
Disease control Recruiting nowThis study is testing an existing adult arthritis drug called bimekizumab in children and teenagers with specific types of juvenile arthritis. The main goals are to see how much of the drug gets into the bloodstream and to check its safety when given as an injection. The trial wi…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
3-Year safety check for Kids' arthritis and Behçet's disease medication
Disease control Recruiting nowThis study follows children who have already been taking apremilast for Behçet's disease mouth ulcers or juvenile psoriatic arthritis to check its long-term safety over three more years. It involves about 48 children aged 2-17 who completed a previous one-year study. Researchers …
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Six-Year drug test for kids with painful arthritis
Disease control Recruiting nowThis study aims to understand how a medication called secukinumab behaves in children's bodies and whether it's safe for long-term use. It will follow about 20 children aged 2 to 18 with juvenile psoriatic arthritis for up to six years. Researchers will give the medication throug…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New arthritis drug tested in kids offers hope for pain relief
Disease control Recruiting nowThis study is testing whether a new injectable medication called risankizumab is safe and effective for children with juvenile psoriatic arthritis, a condition causing painful, swollen joints. About 40 children worldwide will receive either risankizumab or an approved drug called…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New hope for kids with arthritis and skin condition
Disease control Recruiting nowThis study is testing a pill called deucravacitinib to see if it can control joint pain, swelling, and skin symptoms in children and teenagers with juvenile psoriatic arthritis. It will involve about 60 participants aged 5 to 18 who have tried other treatments that didn't work we…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC